What role does stereotactic ablative radiotherapy have in advanced castrate-resistant prostate cancer?

被引：2
|
作者：
Phillips, Ryan [1 ]
Ost, Piet [2 ]
Tran, Phuoc T. [1 ,3 ,4 ]
机构：
[1] Johns Hopkins Univ, Dept Radiat Oncol & Mol Radiat Sci, Baltimore, MD 21218 USA
[2] Univ Ghent, Dept Radiat Oncol & Expt Canc Res, Ghent, Belgium
[3] Johns Hopkins Univ, Dept Oncol, Baltimore, MD 21218 USA
[4] Johns Hopkins Univ, Dept Urol, Baltimore, MD 21218 USA
来源：
FUTURE ONCOLOGY | 2017年 / 13卷 / 24期
关键词：
castration-resistant prostate cancer; neoplasm metastasis; neoplasm recurrence; oligometastasis; prostate cancer; stereotactic ablative radiotherapy; stereotactic body radiation therapy; ANDROGEN DEPRIVATION; BODY RADIOTHERAPY; LUNG-CANCER; THERAPY; HISTORY;
D O I：
10.2217/fon-2017-0337
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
[No abstract available]
引用
收藏
页码：2121 / 2124
页数：4
相关论文
共 50 条
  • [31] The role of radiation therapy in the treatment of metastatic castrate-resistant prostate cancer
    Rose, Jim N.
    Crook, Juanita M.
    THERAPEUTIC ADVANCES IN UROLOGY, 2015, 7 (03) : 135 - 145
  • [32] Singapore Cancer Network (SCAN) Guidelines for the Management of Advanced Castrate-Resistant Prostate Cancer
    Ng, Quan Sing
    Kanesvaran, Ravindran
    Tan, Min-Han
    Tan, Yew Oo
    Tay, Miah Hiang
    Toh, Chee-Keong
    Wong, Alvin
    Cheng, Ruijun
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2015, 44 (10) : 397 - 405
  • [33] What Predicts Minimal Response to Abiraterone in Metastatic Castrate-resistant Prostate Cancer?
    Davies, Rhian Sian
    Smith, Christian
    Button, Michael Robert
    Tanguay, Jacob
    Barber, Jim
    Palaniappan, Nachiappan
    Staffurth, John
    Lester, Jason Francis
    ANTICANCER RESEARCH, 2015, 35 (10) : 5615 - 5621
  • [34] Efficacy of Psma Pet-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer
    Henkenberens, C.
    Schmeel, L.
    Sarria, G.
    Giordano, F.
    Christiansen, H.
    Derlin, T.
    von Klot, C.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2021, 197 (SUPPL 1) : S161 - S161
  • [35] Efficacy of PSMA PET-Guided Radiotherapy for Oligometastatic Castrate-Resistant Prostate Cancer
    Henkenberens, Christoph
    Derlin, Thorsten
    Bengel, Frank
    Ross, Tobias L.
    Kuczyk, Markus A.
    Giordano, Frank A.
    Sarria, Gustavo R.
    Schmeel, Leonard Christopher
    Christiansen, Hans
    von Klot, Christoph A. J.
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [36] Personalised molecular radiotherapy treatment planning in castrate-resistant prostate cancer metastatic to bone
    Denis-Bacelar, A. M.
    Divoli, A.
    Chittenden, S.
    Du, Y.
    Dearnaley, D. P.
    O'Sullivan, J. M.
    Frisch, K. J.
    Flux, G. D.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2014, 41 : S271 - S271
  • [37] Current clinical trials in castrate-resistant prostate cancer
    Petrylak D.P.
    Current Urology Reports, 2011, 12 (3) : 173 - 179
  • [38] Abiraterone for the Treatment of Metastatic Castrate-Resistant Prostate Cancer
    Beckett, Robert D.
    Rodeffer, Kathryn M.
    Snodgrass, Rachel
    ANNALS OF PHARMACOTHERAPY, 2012, 46 (7-8) : 1016 - 1024
  • [39] Future Directions in Castrate-Resistant Prostate Cancer Therapy
    Antonarakis, Emmanuel S.
    Carducci, Michael A.
    CLINICAL GENITOURINARY CANCER, 2010, 8 (01) : 37 - 46
  • [40] Treatment sequencing in metastatic castrate-resistant prostate cancer
    Sartor, Oliver
    Gillessen, Silke
    ASIAN JOURNAL OF ANDROLOGY, 2014, 16 (03) : 426 - 431
12345